Back to BR Brookstone Capital Management
TGTX
Showing 8 of 17 quarters
Position history for BRBrookstone Capital Management's holdings in TG Therapeutics, Inc.
Yes. Brookstone Capital Management holds 17,521 shares of TGTX (TG Therapeutics), worth $977,321, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Brookstone Capital Management has held TGTX since Q3 2022, across 17 quarterly 13F filings.
Current Value
$977,321
Current Shares
17,521
Total Value Change
+$449,939
Total Shares Change
0
Quarter-by-Quarter History